Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liposoma is a specialized biotechnology company based in Amsterdam that focuses on the development and manufacturing of liposomal formulations for the healthcare, nutraceutical, and pharmaceutical industries. The company utilizes its proprietary LipoCellTech technology to create high-quality, stable liposomal products that significantly enhance the bioavailability of active ingredients. Liposoma operates both as a product developer with its own line of supplements and as a Contract Development and Manufacturing Organization (CDMO) for third-party clients. Their expertise spans from initial research and development to large-scale GMP-compliant manufacturing of liposomal powders and liquids. By leveraging advanced lipid-based delivery systems, Liposoma aims to improve the efficacy of vitamins, minerals, and therapeutic compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liposoma Technology.